Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Luna Innovations, Inc. 301 1st Street, SW, Suite 200 ROANOKE VA 24011 USA

UEI: SLED_D738B080095C6CA7

Luna Innovations, Inc. 301 1st Street, SW, Suite 200 ROANOKE VA 24011 USA is a federal contractor, registered under UEI SLED_D738B080095C6CA7. It has been awarded $1,999,997 in federal contracts. Primary work spans Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

Contact Information

Registration and classification details

Registration

UEI Code

SLED_D738B080095C6CA7

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

$2.0M100%

Awards by NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)$2.0M100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with Luna Innovations, Inc. 301 1st Street, SW, Suite 200 ROANOKE VA 24011 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for Luna Innovations, Inc. 301 1st Street, SW, Suite 200 ROANOKE VA 24011 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in Luna Innovations, Inc. 301 1st Street, SW, Suite 200 ROANOKE VA 24011 USA's top NAICS codes and agencies

U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)

Solicitation # W911PT26SC001

The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.

POSTED

about 20 hours ago

DEADLINE

"Provide specialized piping expertise overseeing the Craft Labor/Corrosion Control subcontractor for field modifications at KSC including but not limited to fabrication and installation of piping spool pieces, piping & tubing supports, flared & welded tub

Solicitation # 80NSSC26945986Q

NASA Shared Services Center

POSTED

about 20 hours ago

DEADLINE

Scientific Data Management and Publication SupportThe Scientific Data Management and Publication Support subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, focuses on the dissemination of data, tools, and technologies for prime contractors involved in NIDCD medical research projects. The selected provider will manage resource sharing between laboratories and the NIDCD, assist in the preparation of scientific publications, and implement NIH Data Management and Sharing plans. These tasks must be executed using statistical software and secure data repositories while maintaining strict adherence to NIH cybersecurity guidelines. The primary deliverables for this engagement include the provision of disseminated data sets and the completion of published research papers. This opportunity falls under NAICS code 541715 and has a response deadline of March 5, 2027.

National Institutes Of Health

POSTED

DEADLINE

Human Temporal Bone and Fresh Ear Tissue Processing LaboratoryThis subcontract for the National Institutes of Health involves the receiving and processing of human temporal bones and fresh ear tissue to support research network projects for the NIDCD. The selected provider will be responsible for obtaining specimens from the National Hearing and Balance Organ Donor Program, processing inner and middle ear tissues, scanning slides, and summarizing donor medical records. Final deliverables include the processed specimens, high-resolution scanned images, and comprehensive annotated data. To execute these tasks, the contractor must possess specialized high-resolution slide scanning equipment and maintain strict biohazard containment protocols. Additionally, the provider is required to maintain an active IRB certification throughout the duration of the project. This effort falls under NAICS code 541715 and is managed under the Department of Health and Human Services.

National Institutes Of Health

POSTED

DEADLINE

in about 1 year

Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

Solicitation # RFA-DC-28-002

Solicitation RFA-DC-28-002 is a Notice of Funding Opportunity from the National Institutes of Health, specifically the National Institute on Deafness and Other Communication Disorders, to establish a Coordinating Center for the NIDCD National Human Ear Resource Network. This collaborative network provides human inner and middle ear tissues to researchers for basic and clinical studies aimed at advancing the treatment of auditory and vestibular disorders. The Coordinating Center is responsible for maintaining network cohesiveness through the planning of workshops, symposia, and regular meetings, providing updates to laboratories, and managing communication with the public and scientific community regarding tissue donation. The maximum project period is five years, with a budget limit of 200,000 dollars in direct costs per year. Applicants, including for-profit organizations and small businesses, must maintain active registrations in SAM, eRA Commons, and Grants.gov. Proposals are evaluated based on the significance of the proposed center and the qualifications of the investigators, with additional reviews for human subject protections, inclusion policies, and the use of vertebrate animals. Key requirements include a structured Data Management and Sharing Plan and adherence to cybersecurity guidelines, including a 48-hour incident reporting window. The application process is entirely electronic and requires several standard PHS and SF424 forms, with a response deadline of March 5, 2027.

National Institutes Of Health

POSTED

DEADLINE

National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

Solicitation # RFA-DC-28-001

Solicitation RFA-DC-28-001 is a Notice of Funding Opportunity issued by the National Institutes of Health under the Department of Health and Human Services to support the NIDCD National Human Ear Resource Network. The objective is to maintain a collaborative network of laboratories that serve as a national technological resource, providing human inner and middle ear tissues to researchers for basic and clinical studies to advance the treatment of auditory and vestibular disorders. The scope of work includes processing human temporal bones from the National Hearing and Balance Organ Donor Program, uploading images and medical data to EarBase, sharing gene-expression data via the gEAR repository, and providing technical instruction to increase the number of skilled researchers in the field. The NIDCD intends to commit 3.6 million dollars in FY 2028 to fund up to six awards, with a maximum project period of five years. Individual awards are limited to 450,000 dollars in direct costs per year, with an additional 150,000 dollars available for specific subawards. Applications are due on March 05, 2027, and November 01, 2027, with staggered start dates ranging from July 2027 to July 2028. Evaluation is based on the experience of the investigators, the adequacy of the institutional environment, and the protection of human subjects. Applicants must maintain active SAM registration and a Unique Entity Identifier, and they must provide a Data Management and Sharing Plan and a Material Transfer Agreement. Compliance with the Cybersecurity Act of 2015 is required, including the development of an incident response plan and notification of cybersecurity incidents within 48 hours of discovery.

National Institutes Of Health

POSTED

DEADLINE

in about 1 year

Silviculture Growth & Yield Modelling SpecialistThe Silviculture Growth and Yield Modelling Specialist subcontract supports prime contractors on projects for the Province of British Columbia's Ministry of Forests. The selected specialist will perform advanced statistical analysis and growth and yield modelling, specifically utilizing the Mixedwood Growth Model to establish stocking standards for conifer, broadleaf, mixedwood, and successional forests. A primary objective of the role is the creation of algorithms designed to project stand attributes based on data gathered from free growing surveys. Candidates must possess advanced proficiency in statistical analysis software and extensive expertise with the Mixedwood Growth Model to successfully deliver the required projection algorithms and modelled results. This opportunity was posted on October 19, 2026, with a response deadline of October 29, 2026.

Ministry of Forests

POSTED

DEADLINE

Mental Health Screening Tool Array DesignThis subcontract, titled Mental Health Screening Tool Array Design, involves providing clinical content and validated screening tools to prime contractors working on Illinois State Board of Education projects. The primary objective is to develop specialized tool arrays capable of identifying childhood mental health challenges related to internalizing, externalizing, and trauma. To ensure clinical efficacy and legal compliance with Public Act 104-0032, the tools must be optimized for administration in under ten minutes. The final deliverable consists of a validated set of screening tools fully integrated into the designated platform. This project is managed under the Community Residential Services Authority for the state of Illinois.

COMRESSERVAUTH586 - Community Residential Services Authority

POSTED

DEADLINE

Notice of Correction to Award Information and Application and Submission Information for PA-27-037 "Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)"

Solicitation # NOT-OD-26-091

This notice provides corrections to the award and application information for the Predoctoral to Postdoctoral Transition Award (Parent F99/K00), specifically for solicitation NOT-OD-26-091 issued by the National Institutes of Health. The primary updates involve the removal of Kirschstein-NRSA support period limitations. Eligible individuals may now receive up to five years of aggregate support, consisting of up to two years at the F99 predoctoral level and up to three years at the K00 postdoctoral level. Additionally, the notice clarifies that a Certification Letter is no longer required for these applications, and corresponding instructions have been removed from the SF424(R&R) Other Project Information section. These changes are effective for the application due date of August 8, 2026. For further inquiries, the Division of Biomedical Research Workforce serves as the primary point of contact.

National Institutes Of Health Office Of The Director

POSTED

DEADLINE

Notice of NIBIB Participation in PA-27-037: Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)

Solicitation # NOT-EB-26-005

The National Institute of Biomedical Imaging and Bioengineering is joining the Predoctoral to Postdoctoral Transition Award (Parent F99/K00), effective for applications received on or after December 08, 2026. This funding opportunity is designed for researchers transitioning from predoctoral to postdoctoral training, provided that clinical trials are not involved. All submitted applications must align with the specific missions of the participating Institutes and Centers. This update expands the list of participating organizations and agency contacts to include the National Institute of Biomedical Imaging and Bioengineering and its Chief Grants Management Officer. The award is supported by a wide array of National Institutes of Health offices and centers, including the National Cancer Institute and the National Institute on Aging, among others. All other terms and conditions of the original notice of funding opportunity remain unchanged.

National Institute Of Biomedical Imaging And Bioengineering

POSTED

DEADLINE

Notice of FIC Participation in PA-26-002 "NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)"

Solicitation # NOT-TW-26-002

The Fogarty International Center is participating in the NIH Collaborative International Research Project, identified as PA-26-002. This funding opportunity is effective for applications submitted on or after January 25, 2027. The program is designed for collaborative international research projects and allows for optional clinical trials. A wide array of NIH Institutes and Centers are participating organizations, and applications must align with their specific missions. Additionally, the Office of Research on Women's Health, the INCLUDE Project, and the Office of Data Science Strategy may provide co-funding for assigned applications. All other terms and conditions of the original notice of funding opportunity remain unchanged.

POSTED

DEADLINE

Thermal Performance & Dielectric Testing LaboratoryThis subcontract opportunity is for a Thermal Performance and Dielectric Testing Laboratory to provide independent testing and validation services for prime contractors supporting USAF AFLCMC/WAR F-22 cooling fluid projects. The selected provider will be responsible for evaluating low-temperature viscosity, high-temperature stability, and dielectric strength utilizing specialized equipment such as viscosity meters and stability chambers. The final deliverables for this engagement include comprehensive technical test reports and performance validation data. To be eligible, the contractor must be a domestic U.S. company and hold ISO/IEC 17025 accreditation. The work is associated with NAICS code 541715 and will be performed at Wright Patterson AFB. Interested parties must submit their responses by November 3, 2026.

FA8611 Aflcmc Wauk F22

POSTED

DEADLINE

Clinical Trial Management (Phase I/II)This subcontract opportunity involves the management and execution of Phase I and Phase II clinical trials supporting US Army JPM CBRN Medical projects. The selected provider will be responsible for conducting human safety trials, collecting pharmacokinetic and pharmacodynamic observations, and managing biomarker or human challenge data. Key deliverables include comprehensive clinical trial reports and detailed safety findings to support the development of medical countermeasures. The project requires a partner with established Clinical Research Organization capabilities and specific experience navigating defense-related medical protocols. Performance will take place in Frederick, Maryland, under the oversight of the Department of Defense. Interested parties must submit their responses by November 18, 2026, in accordance with the solicitation posted on October 19, 2026.

POSTED

DEADLINE

Biopharmaceutical Platform Design & DevelopmentThe Biopharmaceutical Platform Design and Development subcontract, issued by the Department of Defense under agency W6QK Acc-Apg, focuses on the design and technical development of prophylactic platform technologies for US Army JPM CBRN Medical projects. The scope of work involves developing mechanisms of action, selecting delivery routes, establishing formulation stability profiles, and performing comprehensive in vitro and in vivo testing to evaluate toxicology, protective efficacy, and immunogenicity. The successful contractor must possess specialized expertise in advancing Technology Readiness Levels and Manufacturing Readiness Levels for CBRN pathogens to deliver prototype candidates and detailed technical data packages. Performance for this effort is centered in Frederick, Maryland, with a response deadline set for November 18, 2026.

POSTED

DEADLINE

HERMES BAA CALL: Rotating Detonation Rocket Engine-Combined Cycle (RDRE-CC) Flight Demonstration

Solicitation # FA9300-20-S-0001-CALL-RDRE-CC

The Air Force Research Laboratory Rocket Propulsion Division is seeking innovative research and development to advance Rotating Detonation Rocket Engine-Combined Cycle propulsion systems from Technology Readiness Level 3 to TRL 6. This effort aims to culminate in a ground-launched, sounding-rocket-boosted flight demonstration to support future High-Speed Affordable Mass Munitions. The anticipated period of performance for awarded contracts is between 36 and 48 months. This is a two-step solicitation process under the HERMES Broad Agency Announcement. Step one requires the submission of a white paper by November 16, 2026, which must be limited to ten pages with an optional five-page technical appendix. Only offerors with high technical merit will be invited to step two to submit full technical and cost proposals. Due to the sensitive nature of the technology, detailed requirements are restricted to U.S. Government agencies and vetted contractors with an active Joint Certification Program registration and a valid CAGE code.

FA9300 Aftc Pzr

POSTED

DEADLINE

CY28 FFP Services

Solicitation # SN-27-0002

The Space Development Agency intends to issue a sole source, firm-fixed-price contract modification to SpaceX to maintain a satellite processing and integration facility in Santa Barbara, California. This facility is designed to accommodate up to 21 satellites and their associated dispenser hardware, providing essential services including post-transport functional testing, mechanical and electrical mating, and integrated payload stack encapsulation. The modification is expected to be awarded in December 2026 with an estimated value of 15,000,000 dollars, extending the period of performance for one year. This action is being taken under the authority of FAR 6.302-1, as SpaceX is identified as the only responsible source capable of satisfying the agency's requirements. This notice is for informational purposes and is not a request for competitive proposals.

FA2401 Space Development Agency Sda

POSTED

DEADLINE

L-PBF Development of ODS Alloys for Recording Methane/Oxygen Combustion Properties

Solicitation # 80NSSC27946801Q

The NASA Shared Services Center is seeking capability statements for a project focused on the laser powder bed fusion (L-PBF) development of oxide dispersion strengthened (ODS) and burn-resistant nickel-based alloys, including GRX-810, GRX-810+, and GRX-900. The scope of work involves advanced process development and parameter optimization using an EOS M280 system to achieve a relative density of 99.9 percent or higher. Key requirements include the production of test coupons and representative components, the supply of at least 600 kg of GRX-810 powder, and strict adherence to NASA-STD-6030 for mechanical validation. All deliverables must be shipped to the Marshall Space Flight Center in Huntsville, Alabama. This procurement is being conducted as a commercial items or services acquisition under FAR Part 12, with NAICS code 541715. NASA intends to issue a sole source contract to North American Manufacturing Pros LLC under FAR 12.102(a); however, the agency is requesting capability statements from other interested organizations to determine if the procurement should be conducted on a competitive basis. Interested parties must submit their qualifications to the primary point of contact, Cara Craft, by October 22, 2026. The contract requires rigorous documentation, including real-time reporting of anomalies and full powder traceability certifications covering chemical composition and particle morphology.

NASA Shared Services Center

POSTED

DEADLINE

Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination

Solicitation # HT9427-26-R-E020

The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.

Defense Health Agency

POSTED

DEADLINE